This inventor holds 4 USPTO granted patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2002-2006.
Company Filing History:
Years Active: 2002-2006
Title: Karen Jansen: Innovator in Polyamide Nucleic Acid Oligomers
Introduction
Karen Jansen is a prominent inventor based in Jacksonville, FL (US). She has made significant contributions to the field of biotechnology, particularly in the development of polyamide nucleic acid (PNA) oligomers. With a total of 4 patents, her work focuses on methods and materials that enhance biological responses in living cells.
Latest Patents
One of her latest patents involves using polyamide nucleic acid oligomers to engender a biological response. This invention provides methods for extracellularly administering PNA oligomers to living cells, ensuring that these oligomers can cross biological barriers and elicit a sequence-specific biological response. Additionally, the invention outlines methods for orally administering PNA oligomers to animals, allowing for similar biological interactions. The patent also includes the development of sense and antisense PNA oligomers that modulate transcription and translation, as well as mismatch PNA oligomers that influence the degree of the biological response. Furthermore, it offers methods for detecting PNA oligomers in biological samples and screening potential oligomers for their ability to induce specific biological responses.
Career Highlights
Karen Jansen is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to advance her research in the field of biotechnology. Her innovative work has positioned her as a key figure in the development of new therapeutic methods using PNA oligomers.
Collaborations
Throughout her career, Karen has collaborated with notable colleagues, including Elliott Richelson and Beth Marie Tyler. These partnerships have contributed to the success and impact of her research.
Conclusion
Karen Jansen's contributions to the field of biotechnology through her innovative work with polyamide nucleic acid oligomers highlight her role as a leading inventor. Her patents not only advance scientific understanding but also pave the way for potential therapeutic applications.